Literature DB >> 31773975

New potent STS inhibitors based on fluorinated 4-(1-phenyl-1H-[1,2,3]triazol-4-yl)-phenyl sulfamates.

Mateusz Daśko1, Sebastian Demkowicz2, Janusz Rachon2, Karol Biernacki2, Justyna Aszyk3, Witold Kozak4, Maciej Masłyk5, Konrad Kubiński5.   

Abstract

A series of fluorinated analogs based on the frameworks of 4-(1-phenyl-1H-[1,2,3]triazol-4-yl)-phenyl sulfamates have been synthesized as steroid sulfatase (STS) inhibitors. The design of chemical structures of new potential STS inhibitors was supported by molecular docking techniques to identify potential interactions between inhibitors and amino acid residues located in the STS active site. The STS inhibitory potency was evaluated on STS isolated from human placenta. We found that compounds substituted with fluorine atom at the meta position demonstrated the highest inhibitory effects in enzymatic STS assay. The most active analog 12e - inhibited STS enzyme with the IC50 value of 36 nM.

Entities:  

Keywords:  STS inhibitors; Triazoles; breast cancer; steroid sulfatase; sulfamates

Mesh:

Substances:

Year:  2019        PMID: 31773975     DOI: 10.1080/10286020.2019.1680642

Source DB:  PubMed          Journal:  J Asian Nat Prod Res        ISSN: 1028-6020            Impact factor:   1.569


  2 in total

1.  New potent steroid sulphatase inhibitors based on 6-(1-phenyl-1H-1,2,3-triazol-4-yl)naphthalen-2-yl sulphamate derivatives.

Authors:  Olga Ciupak; Mateusz Daśko; Karol Biernacki; Janusz Rachon; Maciej Masłyk; Konrad Kubiński; Aleksandra Martyna; Sebastian Demkowicz
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

2.  Development of Sulfamoylated 4-(1-Phenyl-1H-1,2,3-triazol-4-yl)phenol Derivatives as Potent Steroid Sulfatase Inhibitors for Efficient Treatment of Breast Cancer.

Authors:  Karol Biernacki; Olga Ciupak; Mateusz Daśko; Janusz Rachon; Witold Kozak; Janusz Rak; Konrad Kubiński; Maciej Masłyk; Aleksandra Martyna; Magdalena Śliwka-Kaszyńska; Joanna Wietrzyk; Marta Świtalska; Alessio Nocentini; Claudiu T Supuran; Sebastian Demkowicz
Journal:  J Med Chem       Date:  2022-03-02       Impact factor: 7.446

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.